Georgia

Georgia's life sciences ecosystem has emerged as a premier global destination for biotechnology innovation and pharmaceutical manufacturing, consistently outpacing national growth trends.

As the recognized "Center of Global Health," the state is home to the Centers for Disease Control and Prevention (CDC) and a dense cluster of over 4,000 life sciences organizations.

Georgia is best known for its robust medical device manufacturing sector, with industry leaders like Alcon and Medtronic leveraging the state's advanced smart factory capabilities.

The biopharmaceutical landscape is equally diverse, featuring significant operations from global giants such as Takeda, Sanofi and Boehringer Ingelheim.

Academic research serves as a primary engine for this growth, anchored by world-class institutions like Emory University and Georgia Tech, which drive breakthroughs in regenerative medicine, neurotechnology and immunoengineering.

Rapid expansion in healthcare innovation is further fueled by a thriving digital health corridor in Metro Atlanta, supporting over 250 companies focused on health IT and AI-driven diagnostics.

Strategic investments in biomanufacturing capacity and specialized tax credits ensure a competitive environment for contract research organizations (CROs) and clinical-stage startups.

With a deep talent pipeline of recent life sciences graduates, Georgia offers an unparalleled workforce for the future of the bioeconomy.

This collaborative ecosystem seamlessly integrates public-private partnerships, such as the Georgia Research Alliance, to accelerate the commercialization of life-saving therapies.